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Abstract: 
Interpersonal attachment and drug addiction share many attributes across their behavioral and 
neurobiological domains including how they grow and decay within an individual’s motivational 
repertoire.  Understanding the overlapping brain circuitry of attachment formation and addiction 
illuminates a deeper understanding of the pathogenesis of trauma-related mental illnesses and 
comorbid substance use disorders, and the extent to which ending an addiction is complicated by 
being a sort of mourning process.  Attention to the process of addiction recovery—as a form of 
grieving— in which Kubler-Ross’s Stages of Grief and Prochaska’s Stages of Change are 
ultimately describing complimentary viewpoints on a general process of neural network and 
attachment remodeling,  could lead to more effective and integrative psychotherapy and 
medication strategies.   
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LIFE GOES ON 
 I can’t remember the first time we met…  
 But I do know that from the beginning 
 We formed a lifetime bond. 
 Maybe many life time bonds. 
 
You were comfortable, familiar 
 As if I had known you forever.   
It was so easy to just be with you.   
I think everyone felt that way around you.   
 
Actually when I think about it, 
I think you were around much longer, 
And before we even met 
Maybe even before I was born. 
When I look at old pictures of my family 
 I see you there too.   
In the faces and in the places. 
 
What a loyal friend you have been to all of us. 
Showing up at every occasion: 
Celebrations, quiet moments with friends, times of deep despair,  
And even when no one else was there.   
Never intrusive really, sometimes not even noticeable,  
Sometimes you were the life of the party.   
When I met you, I knew I had found a friend forever.  
 I knew you would never leave me,  
And you always made me feel better no matter what.   
When I felt lonely, or sad, anxious, angry, or even happy.   
You were always there.   
We had sooooo much fun together.   
All of us loved you so much. 
 
I’m not sure when all that changed;  
You exited as subtly and quietly as you entered.  
Your power to make me feel stronger slipped away gradually, almost without notice.   
But in your wake you left your mark of betrayal and heartache.   
You tried to take everything away. 
 
But life goes on you see,  
New generations are on the horizon, 
And we’ll be ok.                                                                    -SCW 
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INTRODUCTION 
As suggested in this poetic dialogue with nicotine addiction, many parallels exist between 
the experiences individuals have in their attachments to loved ones, and their attachments to 
drugs in addiction.  In the last decade, neuroscience has converged with clinical observation to 
suggest a new understanding of the biological and behavioral aspects of drug addiction as being 
not just a disease of motivation (Chambers, Bickel, & Potenza, 2007; Kalivas & Volkow, 
2005)—but an illness of neural systems that normally generate and support our crucial 
attachments to each other (Burkett & Young, 2012).    
Emerging data and theory from the fields of anthropological evolution and social 
neuroscience advanced by Harari and others (Harari, 2015; Sherwood, Subiaul, & Zawidzki, 
2008)  provide a compelling story of how humans have been so evolutionarily successful and 
dominant on our planet.  Because of our uniquely powerful brain capacities for creating and 
maintaining social bonds and group cohesion— through the invention, communication, and 
projection of shared imaginary fictions—homo sapiens are able to generate concerted action on 
an incomparable scale and degree of potency, overcoming the limits of time and geography that 
constrain all other species.   Clearly, our capabilities of language, abstract thinking, social 
cognition and our drive to form and keep social bonds—long before they made us so powerful 
that we could collectively destroy the planet through nuclear war, or climate change, or more 
optimistically, put people on the moon—have been keys to our evolutionary success.  Now, 
understanding how our brain systems that allow our gifts of social cognition and attachment, 
could also be our ‘Achilles Heel’ in terms of vulnerabilities to  mental illness and addiction,  has 
become an important new frontier in psychiatric neuroscience. 
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This paper will explore new perspectives on addictive disease as informed by attachment 
neuroscience and theory that could inform methods for treatment and recovery, and open novel 
research avenues in addiction and dual diagnosis care.  A brief overview of the similarities and 
overlaps between human attachment and addiction on behavioral and brain levels will set the 
stage for understanding what is happening in the struggle for recovery, and what needs to happen 
therapeutically to help patients more efficiently and successfully detach from their addictions.  A 
reinterpretation and synthesis of two of the most influential staging theories in psychiatry:  1) the 
Stages of Grief by Kubler-Ross (Kubler-Ross, 1969), and, 2) Stages of Change by Prochaska & 
DiClemente (Prochaska & DiClemente, 2005), will inform this discussion.   Exploring how the 
stages of grief and the stages of addiction recovery may actually be variants of a more general 
and unified process of attachment adaptation that is at once underpinned by the same brain 
biology and susceptible to shared pathological processes, opens new frontiers for designing more 
powerful treatments that integrate psychotherapies and medications.        
 
ADDICTION AND ATTACHMENT: THE CLINICAL OVERLAP 
 Drug addiction is a neurodevelopmental disease primarily centered in the motivational 
circuits of the brain (Chambers et al., 2007; Chambers, Taylor, & Potenza, 2003; Kalivas & 
Volkow, 2005).  Both DSM criteria and basic research on addiction point to cumulative 
pathological alterations in motivated behavior, and biological changes in the brain’s key 
motivational control center—the Nucleus Accumbens ((NAC) or ventral striatum)— as being 
core to the process of addiction (Self & Nestler, 1995; Volkow, 2004).  The NAC can be 
understood as the principal neural network in the brain that stores, processes, and creates 
motivational representations that guide, sequence and select the behavioral programs we act out 
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(Chambers et al., 2007).  When we are healthy, our motivational system allows us to organize 
and execute behavioral sequences that optimally help us explore the world, procure resources, 
reproduce, take care of our children, and do it all over again.  The NAC is the neurobiological 
seat of our ‘will power’ and it is a primary neurobiological engine that drives our will to survive.  
 Given the extent that our social behavior and motive for cohesion has been so crucial to 
our evolutionary success, it should be no surprise that a substantial portion of the function and 
biophysical real estate of the NAC and its connectivity with other brain regions is devoted to 
mediating social relationships, that is, the formation and maintenance of ‘conspecific’, i.e. 
human to human bonds (but let us not forget our beloved pets which are our inter-species 
attachments!) (Depue & Morrone-Strupinsky, 2005).  In this way, we begin to appreciate that 
much in the same way people feel attached to their families of origin, or how they acquire new 
romantic partners, the acquisition and maintenance of drug addiction could likely be understood 
as a pharmacological exploitation of biological mechanisms that normally generate attachments 
between friends, family and lovers (Burkett & Young, 2012).    
The parallels between falling in love vs. becoming addicted are remarkable.  The early 
stages of both are marked by arousal, euphoria, and increasing preoccupations with the love 
object (person/drug) including a growing desire to be around, and, in some way or another, to 
consume, be consumed by, or merge with the ‘person/drug’.   In more progressed stages, 
separation and withdrawal from the ‘person/drug’ correlates with a sense of loss, dysphoria, 
changes in sleep and appetite, and yearning, all congealing to vigorous efforts to re-establish 
access to the ‘person/drug’.   
Recognizing these parallels brings us to taking a closer look at the extent to which 
addiction is not just a disease of the motivational system, but a disease of the social attachment 
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system of the brain.  In fact, could it be all that it is? Could addiction be a disease purely of 
systems that control attachment and mediate complex social behavior?   
Not likely.  For example, trans-species animal research on addiction shows that drugs that 
are addictive to humans, monkeys and other mammals, are also reinforcing for much lower order 
animals such as C. Elegans worms, which have brains with only 302 neurons (Engleman, Katner, 
& Neal-Beliveau, 2016; Katner, Neal-Beliveau, & Engleman, 2016) and show nothing close to 
the complexity and power of mammalian social behavior.  Also, when animals or people do 
acquire drug addiction, the disease can be quite broad in terms of its destructive effects.  Far 
more than social behavior and obligations are impacted.   In severe addiction, the individual can 
experience a comprehensive loss of motivated behavior spanning social and occupational 
domains of function, not to mention incurring serious psychiatric and somatic damage.  Finally, 
the biological mechanisms involved in addiction are clearly more general than those involved 
specifically in social behavior and attachment.  For example, the pharmacological release of 
dopamine (DA) into the NAC produced by essentially all major addictive drug types, mimics 
endogenously activated DA release that occurs in response to a very wide variety of naturally 
reinforcing and motivating stimuli including food,  sex, game winning,  stress, novelty, and 
social interaction  (Berke & Hyman, 2000; Wise, 1998). 
But with these caveats in mind, the connection between addiction and social attachment 
becomes quite compelling even on the epidemiological level in considering how addictions 
spread or recede like contagious epidemics, how different sub-populations are differentially 
vulnerable to addiction, or differentially resistant to, or responsive to treatment (Christakis & 
Fowler, 2008).  Peer pressure has long been known to propagate drug experimentation among 
adolescents who are also biologically primed to acquire addictive disease while their 
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motivational-behavior repertoires are rapidly expanding to take on adult social, occupational and 
sexual roles (Chambers et al., 2007; Chambers et al., 2003).  And, in drug users of all ages, 
using, sharing, and selling drugs often happens in a highly social context or network (e.g. at the 
party), or more exclusively, in self-selected subgroups that break off from the larger group.  
People not only like to use drugs and alcohol, but they like to do it together, and, they tend to 
spread these ‘resources’ to others they are attached to, or want to be attached to.  Maybe, this is a 
manifestation of ancient mammalian behavior (e.g. where the clan comes together to share the 
consumable resources), and something more neurobiologically intricate, e.g. like a synergistic 
mixing of social or sexual brain reward processes with the reinforcement of drug use (Schneider 
& Irons, 2001).  Regardless, drug use propagates readily across the scaffoldings of human social 
networks, so much so that the epidemiology of drug use ‘outbreaks’ can look remarkably similar 
to,  and even go along with outbreaks of infectious diseases, which are also often propagated via 
social contacts.    
These social dynamics also play into the level of success of individuals who are trying to 
stop using.  Patients who persist in living with family members who are actively using are more 
treatment refractory (Lavee & Altus, 2001; Simmons & Singer, 2006).  On the other hand, a 
major therapeutic mechanism of Alcoholics Anonymous (AA) and professionalized variants of 
12-step Groups, likely involves their offering of social support and reward that comes with not 
using (Galanter, 1993; Moos, 2008).   A key area of addiction treatment research that relates to 
patient’s social behavior focuses on the need for teams to be able to determine what patient 
indicators best predict clinical response.  This area of addiction research, which has become 
increasingly important given the scarcity of treatment resources, infrastructure, and professionals 
that currently exist in proportion to the vast unmet clinical need, has produced a replicated 
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observation that the attachment style of patients, and their capacity to attach to their treatment 
team is a major determinant of their ability to successfully recover (Borelli, Goshin, Joestl, 
Clark, & Byrne, 2010; Caspers, Yucuis, Troutman, & Spinks, 2006; Fowler, Groat, & Ulanday, 
2013; Kassel, Wardle, & Roberts, 2007; Schindler, Thomasius, Petersen, & Sack, 2009; Vaillant, 
1988).  As we will explore next on a more neurobiological level, patients with a variety of 
mental illnesses that impact their attachment functions are more vulnerable biologically to 
acquiring addiction and developing more severe forms of the disease.  At the same time, not all 
psychiatric illnesses that produce deficits in social interaction and/or attachment, always worsen 
addiction vulnerability, and in fact might have the opposite effect.  For example, autism 
spectrum disorders may be somewhat protective against addiction.  Clearly, the causal 
connections between addiction pathogenesis, mental illness, and attachment abnormalities are 
real, but quite complex and nuanced. Understanding the neurobiological substrates that connect 
these phenomena, as introduced next, will be important to developing better treatments for 
patients with dual diagnosis disorders that involve attachment abnormalities. 
          
ADDICTION AND ATTACHMENT: THE NEUROBIOLOGICAL OVERLAP 
The core circuitry of the brain involved in motivational learning and control, the NAC, is 
a key location where addiction pathogenesis takes place (Di Chiara, 2002; Kauer & Malenka, 
2007; Self & Nestler, 1998).  Understanding how motivation works, and what roles the NAC 
plays in relation to other key limbic structures involved in social behavior, can help us begin to 
link disturbances of attachment with the pathogenesis of addiction.   
Motivational programming that takes place in the NAC is strongly regulated and 
informed by direct inputs from the Prefrontal cortex (PFC), Amygdala (AMY), and Ventral 
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Hippocampus (VHIP) (Goto & Grace, 2005; O'Donnell, Greene, Pabello, Lewis, & Grace, 
1999).  In this architecture, executive decision-making and impulse control functions of the PFC 
are integrated with emotional states and affective memories perceived/generated/represented by 
the AMY, along with contextual memory information provided by the VHIP—all on behalf of 
generating an ‘optimal’ motivational representational code within the NAC (Finch, 1996).  In 
turn, this motivational code, calls up, selects, sequences and directs, motor representational codes 
that are generated, stored, modified and played out within the dorsal striatum (Chambers et al., 
2007; Haber, Fudge, & McFarland, 2000; Masterman & Cummings, 1997), which ultimately 
engages the pyramidal motor system (motor cortex/peripheral motor neurons) to output 
behavioral programs (Figure 1).    
Within the NAC, there are a great number of motivational codes that are stored and can 
be ‘called into action.’   Some of these motivational codes are more oriented toward social 
behavior (e.g. the motivation to be nearby and interact with loved ones), while others are more 
oriented toward occupational behavior (e.g. the motivation to leave our family to go on a paid 
business trip).  Thus, differential types or classes of motivation, may or may not be in some 
degree of competition with one another (Clithero, Reeck, Carter, Smith, & Huettel, 2011).  In the 
course of drug addition, an accumulation of addictive drug effects within the NAC, produces a 
pathological introduction and progression of a strong desire (motivation) to procure and use the 
addictive drug(s).  But, this motivation is almost always accompanied by some degree of still 
healthy motivation that the individual also harbors to stop using, e.g. consistent with the DSM 
criteria for addiction as continued drug use despite competing desires or attempts to cut back or 
quit.  When these 2 motivations (to use vs. not to use) are in competition inside the brains of 
people with addiction, it is felt by the patient, and observed by the clinician, as ambivalence.  
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Similarly, in people who are in a relationship that they have “mixed feelings” about, they carry a 
burning question with respect to the attachment, as the punk band The Clash so iconically sang: 
“Should I Stay or Should I Go.”  
So, just as the formation and maintenance of interpersonal attachment resembles drug 
addiction, we should look at their shared neurocircuitry and neurotransmitter systems for 
discovering novel preventative and treatment interventions.  Within the PFC-NAC-AMY-VHIP 
Circuit (Figure 1),  which functional neuroimaging data indicates is involved in experiencing 
romantic love (Bartels & Zeki, 2000), we know that DA neurotransmission is very important, 
mediating the neuroplastic effects of essentially all addictive drugs (nicotine, alcohol, opioids, 
cocaine, amphetamines) (Di Chiara & Imperato, 1988; Wise, 1990).  DA is a key facilitator and 
‘sculptor’ of the molecular, electrical (i.e. physiological) and morphological (e.g. shapes and 
densities of dendrites and spines) aspects of neuroplasticity within the NAC (Nestler & 
Aghajanian, 1997; Robinson, Gorny, Mitton, & Kolb, 2001; Wolf, 2002).  In other words, not 
only does DA efflux signal the presence of motivationally salient information in the NAC, but it 
changes the function, structure and connectivity architecture of NAC neurons. These changes in 
turn, impact the way the NAC ‘reads’ and processes inputs from the PFC, AMY, and VHIP, and 
thus,  the way the NAC communicates with down-stream striatal-motor output structures. In 
essence, certain patterns of DA efflux into the NAC can produce enduring changes in motivation 
underlying the formation of relatively locked-in motor sequences, including habits and 
compulsions that are core to addiction (Chambers et al., 2007). 
A number of excellent reviews with neurobiological depth have now been published 
outlining the evidence for DA and other neurotransmitter systems involved in both addiction and 
social attachment (Burkett & Young, 2012; Depue & Morrone-Strupinsky, 2005; Fletcher, 
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Nutton, & Brend, 2015).  In briefly summarizing this evidence, we know that DA is a general 
motivational and socially relevant reinforcement signal in the NAC.  A host of other 
neurotransmitter and neuro-hormonal systems are also implicated including serotonin, oxytocin, 
vasopressin, corticosteroids, corticosterioid releasing factor, and the endogenous opioid system 
to name a few. Similarly, a broader collection of subcortical structures beyond the NAC, but 
interconnected with it (and the PFC-AMY-VHIP assembly), are invested in governing social 
motivation and behavior. These  include the Septal Nuclei (Septal N. also called Lateral Septum;  
involved in social play and aggression) (Sheehan, Chambers, & Russell, 2004);  the Bed Nucleus 
of the Stria Terminalis (BNST, also often  considered as part of the ‘extended amygdala’;  
involved in social anxiety and sexual behavior)  (Avery, Clauss, & Blackford, 2016; Petrulis, 
2013), and of course the hypothalamus (HypoT;  involved in a wide range of  primitive 
homeostatic, consummatory  and sexual behaviors) (Zha & Xu, 2015) (Figure 1).  Although the 
complexities of these interacting systems do not yet permit us to unravel exactly how they 
govern social motivation and communication, new data-based theories are emerging to suggest 
how they might link attachment, addiction and stress resilience.  For instance, oxytocin is 
strongly implicated in the formation and maintenance of intimate relationships and the maternal-
fetal bond, while it also helps regulate hypothalamic-pituitary axis (HPA) and corticosteroid 
responsivity to external stressors and threats (e.g. creating the sense of relative safety among 
loved ones).  The oxytocin system may serve these functions by facilitating the habit formation 
of behaviors surrounding exclusive relationships, by modulating the way the NAC interacts and 
influences the dorsal striatum (Tops, Koole, H, & Buisman-Pijlman, 2014).   
Among all of these neurotransmitter systems, research on the endogenous opioid system 
offers some of the most compelling insights into the overlap between attachment and addiction. 
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The endogenous opioid system is not only involved in drug reinforcement and pain perception 
via activity at µ-opiate receptors in the NAC and cortico-thalamic centers; it also regulates early 
attachment formation between infants and their primary care givers (Copeland et al., 2011).  
While injection of opioids or µ-opiate receptor blockers can modulate the formation or 
maintenance of these early attachments, cycles of separations and reunions between mother-
infant pairs have biological effects on the endogenous opioid system, and have behavioral 
similarities with phases of opioid withdrawal and intoxication (Gustafsson, Oreland, Hoffmann, 
& Nylander, 2008; Kalin, Shelton, & Lynn, 1995). 
These observations make it readily conceivable that abnormal patterns of early 
attachment, e.g. marked by chaotic inconsistencies, neglectful and/or abusive interactions, can 
cause a disturbance in the development and function of the endogenous opioid system itself, 
and/or downstream social and motivational networks that this system regulates.  Hence, 
experience-induced ‘malformation’ of the endogenous opioid system in childhood may play a 
causal role in the emergence of borderline personality by early adulthood (Bandelow, Schmahl, 
Falkai, & Wedekind, 2010), which is of course, heavily comorbid with drug addictions (Trull, 
Sher, Minks-Brown, Durbin, & Burr, 2000).  At the same time, early social-environmental 
trauma and chaotic attachment is a major risk factor for adult addiction in rodents and humans 
alike (Lawson, Back, Hartwell, Moran-Santa Maria, & Brady, 2013; Moffett et al., 2007).  
Interestingly, a recent study from our own dual diagnosis clinic has shown that that the 
likelihood a patient will be diagnosed with a personality disorder on initial psychiatric interview 
increases with the number of prescribers providing opioids to that patient in the year prior to the 
interview (Hackman et al., 2014).   
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 The sadomasochism that pervades borderline spectrum illness is also highly suggestive of 
neurodevelopmental misalignments involving pleasure-pain perception, motivational systems, 
and social behavior (Bandelow et al., 2010; Pechtel & Pizzagalli, 2013).  The way borderline 
patients often show a) cycles of impulsive sexuality and self-destructive behaviors in their 
compulsive engagement with abusive romantic partners (Carnes, 1997), and b) extreme binging 
patterns of drug use, can be remarkably similar and intertwined.  Patients engaged in prostitution 
not only typically have childhood histories of sexual and emotional abuse and adult borderline 
symptoms, but their prostitution is often immersed in drug addiction, both as a means to afford 
addictive drugs, and as a context in which they use and dissociate. 
 Early attachment disruption, and early abuse/neglect are often interrelated phenomena 
that have been well known to be key root causes of adult psychopathology (Bowlby, 1988, 1995; 
Harlow, Dodsworth, & Harlow, 1965).   New research is beginning to characterize how these 
experiences represent biologically potent and developmentally neurotoxic events that alter key 
limbic centers like the PFC, AMY and VHIP, leading to mental illness—and the functionality of 
the NAC, leading to increased risk of becoming drug addicted (Heim, Shugart, Craighead, & 
Nemeroff, 2010; Pechtel & Pizzagalli, 2013; Van Dam, Rando, Potenza, Tuit, & Sinha, 2014; 
Vela, 2014).  For example  trauma-spectrum disorders (encompassing PTSD, cluster B 
personality and affective disorders)  are generally highly comorbid with drug addiction,  while 
animal models of these mental illnesses show impairments in neuroplasticity and neurogenesis 
within the VHIP (Chambers, 2013).  In turn,  early neurodevelopmental damage to the VHIP 
increases motivational responsivity to addictive drugs  (i.e. increasing the probability of 
acquiring addiction), by changing the way the NAC and dorsal striatum  respond to their DA-
induced neuroplastic effects (Chambers et al., 2013; Chambers & Self, 2002).              
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In summary, clinical and basic science are showing that brain mechanisms involved in 
attachment and addiction are overlapping and mutually engaged to such a high degree that the 
addicted patient experiences their attachment to their drug (s) as if they were loved ones; as if the 
drug(s) were people they are in a close relationship with.  Pursuing this understanding further 
scientifically and translating it clinically, may improve outcomes in the care of addicted and dual 
diagnosis patients, as considered next.   
 
ADDICTION RECOVERY:  GRIEVING AND ATTACHMENT ADAPTATION 
A helpful framework for understanding the illness that patients with addiction (and 
comorbid mental illness) have, is one that views their disease state as a trap that they need help 
getting out of.  Over time, the addiction has created a pathological limitation of their free will 
and capacity to enact adaptive choices.  It has limited their motivational-behavioral repertoire to 
an abnormally narrow set of ‘programs’ dedicated to acquiring and using drugs at the expense of 
healthy motivations and behaviors (Chambers, 2008).  Mental illness, which is often present to 
some degree as a context for severe addiction, accelerates this process, because it not only 
changes the reinforcing power of addictive drugs (Chambers, Krystal, & Self, 2001), but it 
produces impulsive behavior and narrowing of the motivational-behavioral repertoire even 
before drug use starts to kindle addictive disease (Chambers et al., 2007).  Then, as the drug 
addiction takes hold, drug use generates even more psychiatric symptoms (or worsens those 
already there), while further degrading the decision-making that is needed to perform adaptive 
occupational and social (family) functions.  Notably, some of the earliest known usage of the 
term “addiction” was in Roman antiquity, referring to a bond of slavery, or the state of servitude 
of debtors to lenders or to those whom they owed restitution.  Thus addiction is a trap, or state of 
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servitude and enslavement of the afflicted person, in which wanting, desire, loyalty and behavior 
is constrained to and focused on the drug-object, at the expense of ‘free will’ and often, the 
health and longevity of the patient.                  
Reflecting this pathological behavioral change,  neuroscience research has shown that 
primary motivational circuits  (PFC/NAC/AMY/VHIP) impacted by addiction become 
pathologically inflexible in some of their structural and functional attributes (Chambers et al., 
2007).  Over time, addictive drug use literally begins to wear out and impair mechanisms and 
structures that allow normal neuroplasticity and motivational learning and memory, as reflected 
by multiple interactive pathological processes involving i) physical changes in cortical-striatal 
synaptic spines and dendrites; ii) abnormal regulation of dopamine and endogenous opioid 
neurotransmission; and iii) impaired hippocampal neurogenesis (Chambers, 2013; Hyman, 2005; 
Kalivas & O'Brien, 2008).  More specifically, chronic addictive drug use causes abnormal 
growth in dendritic arborizations and synaptic connectivity in motivational (PFC-NAC) neural 
networks, likely making these systems both ‘forgetful’ of representing already-learned healthy 
motivations, and refractory to acquiring important new motivations.  At the same time, the 
repetitive pharmacological stimulation of dopamine and/or opioid neurotransmission and 
receptors causes the brain to respond with a wide array of homeostatic changes that end up 
diminishing the brain’s capacity to properly use these same systems for signaling related to non-
drug environmental cues and experiences.  Finally, within the hippocampus (which is connected 
with core motivational circuity via VHIP to NAC axons), the chronic-toxic effects of addictive 
drugs to suppress neurogenesis and other forms of plasticity, causes a breakdown in the brain’s 
ability to integrate current and past experience, and to use this information to guide the formation 
of new adaptive motivational programs.   Thus in addiction, the core motivational networks of 
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the brain become structurally and functionally inflexible, much as the behavior of the patient is 
rigidly and compulsively stuck on the drug-turned love object. 
In this framework, we can see the great difficulty of producing a therapeutic rescue and 
liberation of the patient from their imprisoning addiction, because it is also about a ‘love affair’ 
with the drug that is keeping them imprisoned.  Indeed, encouraging a patient to move into 
recovery via Motivational Enhancement Therapy is practically equivalent to convincing them to 
kill a primary, intensively held, and yet pathological relationship.   While reminding us of what a  
successful psychotherapy must sometimes help patients accomplish—the decisive ending of an 
intimate (but destructive) relationship— this framework of ending and mourning the ending of 
an important relationship is routinely evident when observing patients pursuing addiction 
recovery.  For example, drug-relapse dreams are a common experience in early to middle stage 
abstinent patients that can produce a mixture of feelings (fear/anxiety/longing/relief) worth 
discussion in the treatment setting (Christo & Franey, 1996; Johnson, 2001).  Similarly, recurrent 
dreams of loved ones lost are very common in the grieving process, and, while producing 
sadness and/or comfort in the short term, may be healing in the long term (Wray & Price, 2005).  
Given evidence that dreams, and more generally, REM sleep are involved in the consolidation of 
short and long-term memory via PFC-hippocampal intercommunication (Hutchison & Rathore, 
2015), both grief dreams and relapse dreams may reflect a process of healthy adaption to a new 
state where the relationship with the person, or the drug, exists only in memory.  Unfortunately, 
unlike the situation in grieving a dead loved one, it is very much in the power of the addicted 
patient to raise their love object from the dead, so to speak, via relapse!  Because of this relapse 
potential, which typically happens many times in the course of addiction recovery, we can begin 
to appreciate addiction recovery as being like a condition of prolonged or pathological grief.  
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Again, pathological-complicated grief and severe addictions share common risk factors of being 
associated with early adverse experiences, attachment disruptions and various forms of mental 
illness (Zisook & Shear, 2009).  In these contexts, compulsive engagement in masochistic cycles 
of relapse, harm, withdrawal, relapse, harm, withdrawal, etc, with drug use, mirrors patterns of 
Trauma Bonding (Carnes, 1997). 
 The brain is a well-engineered adaptation machine that optimizes its adjustment during 
‘constructive’ phases of relatively stable environments and relationship networks. But it can also 
undergo profound ‘deconstructive’ biophysical changes in response to very drastic changes in 
contexts and psychosocial networks (Liljenstrom, 2003).  The VHIP, PFC, the HPA-
corticosteroid axis and many other neurotransmitter systems including DA, 5-HT, glutamate and 
endogenous opioid system, are all implicated in these drastic change events.  A key concept to 
consider is that optimizing adaptation to new environmental circumstances likely depends on the 
extent to which the neurobiological changes involving these systems can be made proportional 
to the degree and rapidity of environmental change.  In other words, to best adapt to increasingly 
rapid and/or increasingly profound changes in relationships, occupations, geography, etc., the 
brain must literally break itself down to a greater degree, and build itself back up to a greater 
degree, in terms of neural network connection strengths and architectures within cortical-striatal 
limbic networks (Chambers & Conroy, 2007).  Perhaps most concretely, we see evidence for this 
phenomena in terms of hippocampal neurogenesis.  Prolonged stress provocation of the HPA 
axis induces corticosteroid and glutamate release that literally melts down axodendritic 
connectivity, and kills neurons in the hippocampus. This ‘burn down’ is then followed by a 
phase of re-growth of new and different connectivity patterns, underpinned by birth of new 
19 
 
neurons in the hippocampus, that are capable of higher degrees of plasticity compared to older  
neurons (Chambers, Potenza, Hoffman, & Miranker, 2004).   
 An exciting implication of this ‘burn-down/build up’ model of adaptation, of which adult 
hippocampal neurogenesis is a center piece, is that it has broad explanatory power for 
understanding a variety of mental illnesses and comorbid addictions.  Undershooting or 
overshooting the burn down or regenerative phases in proportion to the environmental change (or 
in proportion to each other) may explain differential aspects of PTSD, depression, bipolar 
disorders, personality disorders and schizophrenia (Chambers & Conroy, 2007).  Or, a failure of 
appropriate regeneration produced by certain forms of mental illness and the pharmacological 
effects of addictive drugs may keep the patient trapped in the addicted state, where they cannot 
‘adapt out’ of  harmful and compulsive drug-seeking and taking (Chambers, 2013).   
 With respect to addiction as a pathological attachment that must be extinguished, repaired 
or replaced, the ‘burn-down/build up’ model of brain adaption leads us to consider two of the 
most important and clinically helpful stage models in psychiatry: Kubler-Ross’s stages of Grief 
(Kubler-Ross, 1969), and Prochaska & DiClemente’s Stages of Change  (Prochaska & 
DiClemente, 2005) (Table 1).  Comparing these 2 models side-by-side reveals their shared 
themes and process similarities.  In ‘Denial/Precontemplation’ the environmental need for drastic 
change has presented itself, but the individual is only minimally aware. In 
‘Anger/Contemplation’the individual is aware of the need for change but also their investment in 
the status quo, and so is drawn into a consuming inner conflict, often with substantial emotional 
manifestations, about what to do.  In ‘Bargaining/Preparation’ a decision has been made to enter 
into some kind of change, but the details are not yet worked out. In fact, the individual is often 
caught up in this phase trying to consider how they may retain and develop the ‘best of both 
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worlds’ (which is actually not quite feasible with accepting either someone’s death or partial 
abstinence in addiction).  At face value, ‘Depression/Action’ may seem like the comparison 
where Kubler-Ross and Prochaska are most dissonant, since a state of depression is often 
associated with psychomotor retardation, seemingly inconsistent with a state of ‘action’.  
However, in terms of the burn-down/build up model, we can appreciate that this phase of change 
on the brain level may be intensively active; now, the old connectivity pathways and neural 
networks are literally undergoing demolition as the blueprints and foundations of new 
connectivity architectures are being laid down. In some regards, the individual’s behavior 
becomes changed and restricted as if ‘battening’ down for the storm, while other people are 
moving in to support and protect via individual and group showing of empathy and advice (e.g. 
funerals or early stage group therapy).  Then finally, we have the Acceptance/Maintenance phase 
where neural reconstruction is well underway, where the individual is now optimizing and fine 
tuning their adaptation to their post loved one/post drug using world.  As shown in Table 1, this 
comparison suggests that Kubler-Ross’s and Prochaska’s stages can be synthesized into a more 
General Attachment Adaptation Model with a neuroscientific foundation. This general model 
understands grief and addiction recovery as quite similar and interlinked processes, underpinned 
by substantial neuroplastic revision and remodeling in the brain, consistent with the ‘burn-
down/build-up model’ happening across components of the PFC-NAC-AMY-VHIP  assembly. 
 
DUAL DIAGNOSIS TREATMENT IMPLICATIONS OF THE GENERAL 
ATTACHMENT ADAPTATION MODEL 
 A key to implementing the General Attachment Adaptation Model in the treatment of 
addiction and dual diagnosis patients is understanding addiction recovery as a form of complex 
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grief, and acting on this clinically.  In terms of psychotherapies, this means incorporating 
approaches in the treatment of complicated/pathological grief (Rosner, Pfoh, & Kotoucova, 
2011; Wetherell, 2012; Zisook & Shear, 2009) into individual and group psychotherapies for 
addiction. This incorporation might include recognition that the transition from addiction is a 
period of very hard emotional work, like grieving, where the individual (however obviously 
harmful the drug use was), is undergoing a substantial sense of loss. This loss can be quite 
profound particularly when patients must also give up close relationships and contexts tightly 
associated with drug using, encompassing family, friends and hometowns.   Helping patients 
bear and mourn what are often tremendous and irreplaceable losses to their health, relationships 
and occupational aspirations, caused directly by addiction, is often critical to protecting them 
against  future relapses and worsening depression.  Bringing empathy, honoring patient’s 
humanity and need for connection, relieving them of shame, perhaps even using communal 
rituals, as in the funeral process, could  all be valuable therapeutic ingredients to addiction 
recovery (Mate, 2008; Moore, 1992).  
Clearly, a core strategy of grief therapy to facilitate growth of the individual into new 
healthy pre-occupations, habits and relationships is also critical to addiction recovery (Rosner et 
al., 2011; Wetherell, 2012).  Part of this effort means that therapists, nurses and psychiatrists 
caring for addicted/dual diagnosis patients should operate professionally, not as detached figures, 
but as attachment surrogates, enacting and modeling healthy new relationships that these patients 
need (Lewis, Amini, & Lannon, 2000; Vaillant, 1988).  In essence, a key to successful dual 
diagnosis and addiction care may be the ability of treatment teams to form strong therapeutic 
attachments with patients that can ‘over power’ their pathological attachment to addictive drugs.  
In this work, the clinical team (and researchers in the field of addiction psychotherapies) should 
22 
 
be thinking about ways to individualize care by attending to the diversity of speeds and 
intensities by which different patients, based on their personalities, mental illness comorbidities, 
and attachment styles, are best able to form new therapeutic bonds.  As illustrated by Brian 
Johnson’s, long-term psychoanalysis-facilitated recovery of a patient with heroin addiction, this 
work can be expected to take years for some individuals (Johnson, 2010).   At any rate, 
acknowledging that addiction is a chronic, relapsing disease that needs evidence based-
treatments involving sustained efforts to retrain, remodel and rebuild capacities for empathic 
human attachments, is an acknowledgement that dehumanizing, judging, disconnecting and 
brutalizing mentally ill/addicted people via criminalization and mass incarceration, is a 
catastrophic moral and public health failure. 
While supporting the idea that outpatient longitudinal dual diagnosis treatment settings 
should be natural homes for practicing grief and trauma-informed psychotherapies, the General 
Attachment Adaptation Model, and its neuroscientific foundation also places importance on 
integrating pharmacotherapies (and other ‘mechanical’ brain interventions, like rTMS or brain 
stimulators) into psychotherapeutic interventions, as the norm, rather than exception for 
addiction recovery.  Psychiatric medications are important not only for addressing mental illness 
comorbidities that are found in most patients with severe addictions, but they should facilitate 
cognitive and emotional stability needed for participation in psychotherapies aiming to facilitate 
attachment adaption.  Similarly, medications for addictive disorders that have various 
motivational-brain effects that help patients safely replace or terminate addictive drug use, 
should be incorporated and synergistic with psychotherapies.  An exciting new frontier of 
medication development in this area is the introduction and testing of novel medicines (e.g. 
ketamine, LSD or MDMA analogues) that may be considerably more potent (albeit more risky) 
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in evoking neuroplastic responses in motivational-attachment centers of brain, than what our 
current repertoire of agents may provide.  Such novel medicines might be developed particularly 
to enhance biological events in the ‘burn-down/build up’ transitions necessary for successful 
dual diagnosis recovery.  In addition, new psychotherapeutic approaches such as the Circle of 
Security (Hoffman, Marvin, Cooper, & Powell, 2006), that directly focus on recovering, 
repairing or remodeling attachment behaviors in child-rearing adults who carry their own 
attachment injuries from childhood trauma, may by key to preventing the transgenerational 
transmission of addictions and dual diagnosis disorders within families.  
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Table 1.  Integrating Kubler-Ross and Prochaska’s Stages toward a General Attachment 
Adaptation Model 
Kubler-Ross  Prochaska   
   
Object of  
Transition:         loved one  drug addiction  Any major attachment 
 
 
Stages of  
Transition Stages of Grief Stages of Change General Attachment Adaptation Model 
Denial   Pre-Contemplation Unaware of need to adapt 
 
Anger   Contemplation Aware/Resisting need to adapt 
 
Bargaining  Preparation   Strategizing on how to adapt 
 
Depression  Action   Effort expended to adapt  
 
Acceptance  Maintenance  Significant adaptation has occurred 
 
 
 
 

